Evidence map›Paper›PMID 38285727›Full record

ArticlePLoS computational biology2024

Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study.

Michiel van Boven, Christiaan H van Dorp, Ilse Westerhof, Vincent Jaddoe, Valerie Heuvelman, Liesbeth Duijts, Elandri Fourie, Judith Sluiter-Post, Marlies A van Houten, Paul Badoux and 11 more

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Michiel van BovenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0002-0841-2400
Christiaan H van DorpDepartment of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, United States of America.ORCID 0000-0002-7504-9947
Ilse WesterhofJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Vincent JaddoeErasmus Medical Center, Rotterdam, the Netherlands.
Valerie HeuvelmanErasmus Medical Center, Rotterdam, the Netherlands.
Liesbeth DuijtsErasmus Medical Center, Rotterdam, the Netherlands.
Elandri FourieSpaarne Gasthuis, Hoofddorp, the Netherlands.
Judith Sluiter-PostSpaarne Gasthuis, Hoofddorp, the Netherlands.
Marlies A van HoutenSpaarne Gasthuis, Hoofddorp, the Netherlands.
Paul BadouxRegional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Sjoerd EuserRegional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Bjorn HerpersRegional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Dirk EgginkNational Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Marieke de HoogJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Trisja BoomJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Joanne WildenbeestDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.
Louis BontDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.
Ganna RozhnovaJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Marc J BontenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Mirjam E KretzschmarJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0002-4394-7697
Patricia Bruijning-VerhagenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Funding

Modeling the ecology of tissue-resident T cellsU01AI150680 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FARBER, DONNA L., YATES, ANDREW · 2020 to 2024
$5.0M
NIAID NIH HHS U01 AI150680
6 · The paper itself

Abstract

Household studies provide an efficient means to study transmission of infectious diseases, enabling estimation of susceptibility and infectivity by person-type. A main inclusion criterion in such studies is usually the presence of an infected person. This precludes estimation of the hazards of pathogen introduction into the household. Here we estimate age- and time-dependent household introduction hazards together with within household transmission rates using data from a prospective household-based study in the Netherlands. A total of 307 households containing 1,209 persons were included from August 2020 until March 2021. Follow-up of households took place between August 2020 and August 2021 with maximal follow-up per household mostly limited to 161 days. Almost 1 out of 5 households (59/307) had evidence of an introduction of SARS-CoV-2. We estimate introduction hazards and within-household transmission rates in our study population with penalized splines and stochastic epidemic models, respectively. The estimated hazard of introduction of SARS-CoV-2 in the households was lower for children (0-12 years) than for adults (relative hazard: 0.62; 95%CrI: 0.34-1.0). Estimated introduction hazards peaked in mid October 2020, mid December 2020, and mid April 2021, preceding peaks in hospital admissions by 1-2 weeks. Best fitting transmission models included increased infectivity of children relative to adults and adolescents, such that the estimated child-to-child transmission probability (0.62; 95%CrI: 0.40-0.81) was considerably higher than the adult-to-adult transmission probability (0.12; 95%CrI: 0.057-0.19). Scenario analyses indicate that vaccination of adults can strongly reduce household infection attack rates and that adding adolescent vaccination offers limited added benefit.

Indexed as

COVID-19EpidemicsAdolescentAdultFamily CharacteristicsHumansProspective StudiesSARS-CoV-2

Identifiers

PMID38285727
PMCPMC10852262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.